ASHERBIO

Welcome to the Brand page for “ASHERBIO”, which is offered here for The mark consists of the text asherbio in stylized font. the bottom half of the a appears as a semi-circle.;pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of viral, oncological, and immune system related diseases and disorders; medical preparations for the treatment of viral, oncological, and immune system related diseases and disorders;asher bio;medical research; pharmaceutical research services; pharmaceutical research and development; scientific research for medical purposes in the fields of cancerous diseases, immunotherapy, autoimmune diseases and disorders, and infectious diseases; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of cancer, immunological diseases and disorders, and infectious diseases; research and development of immunotherapies for the treatment of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials;.

Its status is currently believed to be active. Its class is unavailable. “ASHERBIO” is believed to be currently owned by “Asher Biotherapeutics, Inc.”


Owner:
ASHER BIOTHERAPEUTICS, INC.
Owner Details
Description:
The mark consists of the text AsherBio in stylized font. The bottom half of the A appears as a semi-circle.;Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of viral, oncological, and immune system related diseases and disorders; Medical preparations for the treatment of viral, oncological, and immune system related diseases and disorders;ASHER BIO;Medical research; Pharmaceutical research services; Pharmaceutical research and development; Scientific research for Medical purposes in the fields of cancerous diseases, immunotherapy, autoimmune diseases and disorders, and infectious diseases; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of cancer, immunological diseases and disorders, and infectious diseases; Research and development of immunotherapies for the treatment of cancer; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials;
Categories: